| Nome |
# |
|
SMOLDERING MYELOMA: WALKING THROUGH RISK FACTORS AND TENTATIVE CLASSIFICATION SYSTEMS, file dfe4d22b-6165-bb0a-e053-d805fe0a78d9
|
1.051
|
|
ACINETOBACTER BAUMANNII SURVEILLANCE MEASURES IN HAEMATOLOGICAL MALIGNANCIES PATIENTS, file dfe4d22b-9f13-bb0a-e053-d805fe0a78d9
|
1.034
|
|
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION, file dfe4d22b-9eb7-bb0a-e053-d805fe0a78d9
|
1.008
|
|
A MULTICENTRIC STUDY TO EVALUATE THE EFFICACY OF EPOIETIN ZETA (BIOSIMILAR OF EPO ALPHA) IN LOW RISK MYELODISPLASTIC PATIENTS, file dfe4d22b-7a4b-bb0a-e053-d805fe0a78d9
|
998
|
|
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression, file dfe4d22b-a98c-bb0a-e053-d805fe0a78d9
|
975
|
|
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION, file dfe4d22b-9088-bb0a-e053-d805fe0a78d9
|
930
|
|
MYELOID DYSFUNCTION IN SICKLE CELL DISEASE, file dfe4d22b-9087-bb0a-e053-d805fe0a78d9
|
920
|
|
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload, file dfe4d229-95e0-bb0a-e053-d805fe0a78d9
|
82
|
|
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study, file dfe4d22b-dbc4-bb0a-e053-d805fe0a78d9
|
51
|
|
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells, file dfe4d22a-4b55-bb0a-e053-d805fe0a78d9
|
44
|
|
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma, file dfe4d22a-4a5b-bb0a-e053-d805fe0a78d9
|
42
|
|
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells, file dfe4d22e-6b29-bb0a-e053-d805fe0a78d9
|
40
|
|
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts, file dfe4d22e-6c5b-bb0a-e053-d805fe0a78d9
|
38
|
|
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients., file dfe4d22d-2dc7-bb0a-e053-d805fe0a78d9
|
37
|
|
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection, file 3681630c-365a-45fb-bb31-ac0e1d665a38
|
30
|
|
Differences among young adults, adults and elderly chronic myeloid leukemia patients, file dfe4d229-ec71-bb0a-e053-d805fe0a78d9
|
30
|
|
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia, file dfe4d22d-3118-bb0a-e053-d805fe0a78d9
|
29
|
|
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia, file dfe4d228-ff5f-bb0a-e053-d805fe0a78d9
|
27
|
|
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients., file dfe4d22e-db5d-bb0a-e053-d805fe0a78d9
|
26
|
|
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib, file dfe4d22b-5af7-bb0a-e053-d805fe0a78d9
|
25
|
|
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report, file dfe4d22b-886e-bb0a-e053-d805fe0a78d9
|
25
|
|
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents, file dfe4d22d-3cdf-bb0a-e053-d805fe0a78d9
|
25
|
|
Mesenchymal stem cells (MSC) promotes tumor microenvironment transformation driving Granulocyte-like Myeloid Derived Suppressor Cells (G-MDSC) activation in Smoldering and Multiple Myeloma patients, file dfe4d22b-6a18-bb0a-e053-d805fe0a78d9
|
21
|
|
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells., file dfe4d227-2e66-bb0a-e053-d805fe0a78d9
|
20
|
|
The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma, file dfe4d227-8548-bb0a-e053-d805fe0a78d9
|
19
|
|
Rare gastrointestinal lymphomas: the endoscopic investigation, file dfe4d22b-86b7-bb0a-e053-d805fe0a78d9
|
19
|
|
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells, file dfe4d22d-526e-bb0a-e053-d805fe0a78d9
|
19
|
|
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic, file dfe4d22e-6d48-bb0a-e053-d805fe0a78d9
|
17
|
|
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients, file dfe4d227-7db0-bb0a-e053-d805fe0a78d9
|
16
|
|
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib, file dfe4d22c-1ae9-bb0a-e053-d805fe0a78d9
|
16
|
|
Single segment of spleen autotransplantation, after splenectomy for trauma, can restore splenic functions, file dfe4d22e-2110-bb0a-e053-d805fe0a78d9
|
16
|
|
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein, file dfe4d227-0251-bb0a-e053-d805fe0a78d9
|
15
|
|
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases, file 64b8d549-1c6a-4621-92bf-44c802f29b84
|
14
|
|
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma, file 80fb76a3-e21f-4b7b-9d09-0e8bf07676bb
|
14
|
|
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting, file 8a5d94ae-0504-419c-acc4-2b2ac56044dd
|
14
|
|
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance, file b251340d-5551-4459-a5a2-42ad99400fac
|
14
|
|
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM), file dfe4d227-2ffe-bb0a-e053-d805fe0a78d9
|
14
|
|
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53, file dfe4d229-d55d-bb0a-e053-d805fe0a78d9
|
13
|
|
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors, file dfe4d22b-5af8-bb0a-e053-d805fe0a78d9
|
13
|
|
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis, file dfe4d22b-eba3-bb0a-e053-d805fe0a78d9
|
13
|
|
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database, file f4baab77-9259-42ac-b52c-1882083402be
|
13
|
|
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells., file dfe4d227-acca-bb0a-e053-d805fe0a78d9
|
12
|
|
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib, file dfe4d228-abfe-bb0a-e053-d805fe0a78d9
|
12
|
|
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report, file dfe4d229-dcc6-bb0a-e053-d805fe0a78d9
|
12
|
|
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi, file dfe4d22b-961d-bb0a-e053-d805fe0a78d9
|
12
|
|
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma., file dfe4d22b-b1fb-bb0a-e053-d805fe0a78d9
|
12
|
|
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma., file dfe4d22d-2f7d-bb0a-e053-d805fe0a78d9
|
12
|
|
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection, file dfe4d22e-e46d-bb0a-e053-d805fe0a78d9
|
12
|
|
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles., file dfe4d229-3ab3-bb0a-e053-d805fe0a78d9
|
11
|
|
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials, file dfe4d22d-0d2f-bb0a-e053-d805fe0a78d9
|
11
|
|
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab, file 5ae2fe3b-deec-4a15-afd3-9d56d02ada13
|
10
|
|
Bone Marrow BCL2/IgH+ Cells at Diagnosis and Not FCGRIIIA Polymorphism Predict Response in Follicular Non-Hodgkin’s Lymphoma Patients Treated with Sequential CHOP and Rituximab, file 7f7a0c67-224d-49c9-bc7d-c2848286be4d
|
10
|
|
Childhood neurofibromatosis type 2 (NF2) and related disorders: From bench to bedside and biologically targeted therapies [Neurofibromatosi tipo 2 (NF2) e sindromi correlate in età infantile: dalla biologia molecolare alla pratica clinica e nuove terapie con farmaci biologici], file dfe4d229-15f3-bb0a-e053-d805fe0a78d9
|
10
|
|
Use of the word "cured" for cancer patients-implications for patients and physicians: the Siracusa charter, file dfe4d22b-54ae-bb0a-e053-d805fe0a78d9
|
10
|
|
Pomalidomide: when expectations are understated., file dfe4d22b-777b-bb0a-e053-d805fe0a78d9
|
10
|
|
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents, file dfe4d22b-a9b7-bb0a-e053-d805fe0a78d9
|
10
|
|
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma, file dfe4d22b-ad10-bb0a-e053-d805fe0a78d9
|
10
|
|
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study, file dfe4d22b-bff2-bb0a-e053-d805fe0a78d9
|
10
|
|
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study, file dfe4d22b-ce98-bb0a-e053-d805fe0a78d9
|
10
|
|
Hedgehog signaling pathways in multiple myeloma, file 3811a6bc-3f97-421f-aaf5-e69d999851d9
|
9
|
|
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment, file 41b38c14-6098-4682-8512-b78aeccc8a49
|
9
|
|
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma, file 4c8d793b-11ca-448a-9020-593d51ee0d39
|
9
|
|
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field, file 6674fd2a-1d66-493f-a062-6a9e59027748
|
9
|
|
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells, file 9920587d-fe39-4183-9f20-f0ed10cfa219
|
9
|
|
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine, file c889383e-75bf-4e18-bb4d-3ec227cee410
|
9
|
|
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity
together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients, file dfe4d227-203f-bb0a-e053-d805fe0a78d9
|
9
|
|
Chitotriosidase Expression during Monocyte-Derived Dendritic Cells Differentiation and Maturation, file dfe4d227-b572-bb0a-e053-d805fe0a78d9
|
9
|
|
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3, file dfe4d22b-3d37-bb0a-e053-d805fe0a78d9
|
9
|
|
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment, file 2c8b4f41-7f09-4ab6-88c6-f82d472d5913
|
8
|
|
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques, file 8d03a349-46f5-4049-b3ff-5e10d05cd0a5
|
8
|
|
Bone turnover markers in patients with type 1 Gaucher disease, file b3e8310f-4792-4f1d-9599-ec714078f631
|
8
|
|
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation, file dfe4d227-a503-bb0a-e053-d805fe0a78d9
|
8
|
|
Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report., file dfe4d22b-5443-bb0a-e053-d805fe0a78d9
|
8
|
|
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells, file dfe4d22b-bd50-bb0a-e053-d805fe0a78d9
|
8
|
|
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors, file 0478694d-d93f-4e06-9e4c-8b6109c68bcb
|
7
|
|
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases, file 13fed71d-a434-439f-a7b2-0d7d66eb034b
|
7
|
|
Vg9Vd2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells, file 25de2044-a9f7-4afc-ae02-448dfbe89aa4
|
7
|
|
Lenalidomide and Pomalidomide Improve Function and Induce FcγRI/CD64 in Multiple Myeloma Neutrophils, file 2de40493-51ba-4166-b039-5a3a57ec08a8
|
7
|
|
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma, file 389bc9c7-6350-462f-ab2d-e93414320047
|
7
|
|
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib, file 61040104-9d8c-4582-b4a0-cdb86480449b
|
7
|
|
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients, file b02af814-9fa0-402a-95af-d4e3593e9ea8
|
7
|
|
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?, file c609bf56-2697-4099-9305-9cb2b56675a2
|
7
|
|
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey, file c6373205-0993-4a9e-a60d-0a272caabfa0
|
7
|
|
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells, file c64cc785-9540-4c76-beba-e49ce2a3589f
|
7
|
|
QUALITY OF LIFE AT DIAGNOSIS IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA CONSIDERED FIT FOR INDUCTION OF REMISSION CHEMOTHERAPY, file dfe4d22b-4329-bb0a-e053-d805fe0a78d9
|
7
|
|
SMOLDERING MYELOMA: WALKING THROUGH RISK FACTORS AND TENTATIVE CLASSIFICATION SYSTEMS, file dfe4d22b-6164-bb0a-e053-d805fe0a78d9
|
7
|
|
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns, file dfe4d22b-a12b-bb0a-e053-d805fe0a78d9
|
7
|
|
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation., file dfe4d22e-8d2a-bb0a-e053-d805fe0a78d9
|
7
|
|
Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy, file 1a29b1c2-6e6e-4df5-92f5-ee6128e6bb18
|
6
|
|
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens, file 1d425818-7a8b-4e75-9905-c38eda5550fc
|
6
|
|
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network, file 77660544-2a2d-4a7b-bce2-466f647a79a5
|
6
|
|
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report, file 86029422-85af-4841-b2bf-47c3eabb5cfa
|
6
|
|
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data, file 994ee233-3cce-4ead-841a-385abd56772e
|
6
|
|
Uncommon long-term survival in a patient with chronic myeloid leukemia, file ab6d6bef-63ae-4c05-b294-db5e16b8114b
|
6
|
|
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?, file c42b5adf-390d-4e6d-a52c-cbfcb733867b
|
6
|
|
A case of high-risk AML in a patient with advanced systemic mastocytosis, file d660a4be-7a1d-4545-ae41-4f37e0a22f33
|
6
|
|
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression, file dfe4d227-6bc0-bb0a-e053-d805fe0a78d9
|
6
|
|
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC), file dfe4d227-7a28-bb0a-e053-d805fe0a78d9
|
6
|
|
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia, file dfe4d22d-526f-bb0a-e053-d805fe0a78d9
|
6
|
|
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling, file f36cfa9d-7a35-4b0c-8cfb-039a5b69c831
|
6
|
| Totale |
8.262 |